Novel conjugate vaccine decreases incidence of otitis media
- PMID: 17245839
- DOI: 10.1016/j.jpeds.2006.04.031
Novel conjugate vaccine decreases incidence of otitis media
Comment on
-
Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study.Lancet. 2006 Mar 4;367(9512):740-8. doi: 10.1016/S0140-6736(06)68304-9. Lancet. 2006. PMID: 16517274 Clinical Trial.
Similar articles
-
National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States.Pediatrics. 2006 Sep;118(3):865-73. doi: 10.1542/peds.2006-0492. Pediatrics. 2006. PMID: 16950975
-
Efficacy of a pneumococcal conjugate vaccine against acute otitis media.N Engl J Med. 2001 Feb 8;344(6):403-9. doi: 10.1056/NEJM200102083440602. N Engl J Med. 2001. PMID: 11172176 Clinical Trial.
-
Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?Int J Pediatr Otorhinolaryngol. 2006 Feb;70(2):275-85. doi: 10.1016/j.ijporl.2005.06.022. Epub 2005 Sep 2. Int J Pediatr Otorhinolaryngol. 2006. PMID: 16140397 Clinical Trial.
-
Acute bacterial rhinosinusitis and otitis media: changes in pathogenicity following widespread use of pneumococcal conjugate vaccine.Otolaryngol Head Neck Surg. 2008 Mar;138(3):274-8. doi: 10.1016/j.otohns.2007.11.011. Otolaryngol Head Neck Surg. 2008. PMID: 18312870 Review.
-
Pneumococcal conjugate vaccine for young children.Manag Care. 2000 Sep;9(9):49-52, 54, 56-7 passim. Manag Care. 2000. PMID: 11116663 Review.
Publication types
LinkOut - more resources
Full Text Sources